"Clinical Trial to Determine the Efficacy of Vitamin D for Acne Therapy"
|ClinicalTrials.gov Identifier: NCT01694433|
Recruitment Status : Unknown
Verified February 2013 by Jenny Kim, MD, PhD, University of California, Los Angeles.
Recruitment status was: Active, not recruiting
First Posted : September 27, 2012
Last Update Posted : October 21, 2013
|Condition or disease||Intervention/treatment||Phase|
|Acne Vulgaris||Drug: Calcipotriene Drug: Placebo||Phase 2 Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||54 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||Double (Participant, Investigator)|
|Official Title:||Innate Immunity in Acne Vulgaris|
|Study Start Date :||February 2013|
|Estimated Primary Completion Date :||January 2014|
|Estimated Study Completion Date :||December 2014|
Experimental: Calcipotriene Cream
The Calcipotriene Cream will be supplied as 1g daily use individual tubes to be used 2x/day (once in the morning and once in the evening) for 12 weeks.
1g daily BID
Placebo Comparator: Placebo
The Placebo Cream will be supplied as 1g daily use individual tubes to be used 2x/day (once in the morning and once in the evening) for 12 weeks.
1g daily BID
Other Name: Placebo cream manufactured to mimic calcipotriene
- Determine the clinical efficacy of a topical vitamin D analogue for acne therapy by assessing lesion counts (total, inflammatory and non-inflammatory) [ Time Frame: 12 weeks ]
- Clinical Global Improvement (CGI) score [ Time Frame: 12 weeks ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01694433
|United States, California|
|Los Angeles, California, United States, 90095|
|Principal Investigator:||Jenny Kim, MD||UCLA Department of Dermatology|